로딩 중…
지수 로딩 중…
티디에스팜
464280· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩5,530+0.00%
2026-09-18
Financials
Valuation Metrics
티디에스팜's Market Cap is ₩306B. At end of 2025 it was ₩545B. Ranked #2073 of 2,421 in KR market (top 86%), #1328 of 1,640 on KOSDAQ (top 81%), #215 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 93%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 30.58B KRW | KR#2,073/2,421 Sec#215/231 |
| Revenue | 32.90B KRW | KR#1,995/2,421 Sec#137/231 |
| Net Income | 5.15B KRW | KR#1,194/2,421 Sec#78/231 |
| Total Assets | 63.71B KRW | KR#2,071/2,421 Sec#179/231 |
| Net Assets | 44.89B KRW | KR#1,976/2,421 Sec#169/231 |
| Employees | 96 | KR#1,670/2,421 Sec#130/231 |
| Value | ||
| P/E | 5.93x | KR#448/2,421 Sec#18/231 |
| P/B | 0.68x | KR#1,093/2,421 Sec#59/231 |
| PEG | 0.12x | KR#447/2,421 Sec#23/231 |
| P/S | 0.93x | KR#1,336/2,421 Sec#79/231 |
| EV/EBITDA | 7.38x | KR#413/2,421 Sec#17/231 |
| Profitability | ||
| ROE | 11.48% | KR#509/2,421 Sec#35/231 |
| ROA | 8.09% | KR#433/2,421 Sec#32/231 |
| Op. Margin | 17.14% | KR#231/2,421 Sec#21/231 |
| Revenue Growth | 0.37% | KR#1,508/2,421 Sec#150/231 |
| Earnings Growth | 48.88% | KR#563/2,421 Sec#37/231 |
| Financial Health | ||
| Debt Ratio | 41.93% | KR#832/2,421 Sec#96/231 |
| Total Debt | 13.80B KRW | KR#1,522/2,421 Sec#132/231 |
| Cash | 2.76B KRW | KR#2,185/2,421 Sec#207/231 |
| Current Ratio | 2.00x | KR#872/2,421 Sec#99/231 |
| Net Debt/EBITDA | 1.96x | KR#832/2,421 Sec#60/231 |
| Performance | ||
| 1Y Return | -45.57% | KR#1,951/2,421 Sec#168/231 |
| 1M Return | -4.66% | KR#1,762/2,421 Sec#139/231 |
| From 52W High | -49.36% | KR#1,367/2,421 Sec#105/231 |
| 1Y MDD | -56.90% | KR#1,309/2,421 Sec#107/231 |
| Trading | ||
| Volume | 14,981 shares | KR#1,733/2,421 Sec#170/231 |
| Trading Value | 83.0M KRW | KR#1,637/2,421 Sec#162/231 |
| Foreign Own. | 3.52% | KR#1,147/2,421 Sec#105/231 |
| Per Share | ||
| EPS | 932 KRW | KR#752/2,421 Sec#52/231 |
| BPS | 8,118 KRW | KR#1,115/2,421 Sec#80/231 |
Company Info
Established on November 11, 2002, TDS Pharm Co. Ltd. is headquartered in Seongnam-si, South Korea, and specializes in the creation and manufacturing of transdermal drug delivery solutions. Their offerings include items such as cataplasma, plasta, fucidin band, and various prescription pharmaceuticals.